Log in to save to my catalogue

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an op...

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an op...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4927382

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

About this item

Full title

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2016-07, Vol.16 (7), p.809-818

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Cryptococcus is the most common cause of adult meningitis in Africa. We assessed the safety and microbiological efficacy of adjunctive sertraline, previously shown to have in-vitro and in-vivo activity against cryptococcus. Methods In this open-label dose-finding study, we recruited HIV-infected individuals with cryptococcal meni...

Alternative Titles

Full title

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4927382

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4927382

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(16)00074-8

How to access this item